Ann: Trading Halt, page-198

Explains the share price pump over the last couple of days, Bell Potter fingerprints all over it.
No doubt Mr Hester will be writing some positive analysis for clients...

Yet again, your post doesn't go to substance.
What if his analysis is well considered and astute?

My observation of Hester is he's one of the standout analysts in the webinars who has a full understanding of the dynamics involved, and the enormous potential of the technology, and of the limitations of the FDA. AND he's located here in Australia.
That thins out the crowd because at the webinars most of the really smart analysts are US-based but hamstrung by their fund metrics and other pressures.

Unlike you, Hester doesn't just go for hair-triggers nor cheap slogans.

The man has gravitas.